Introduction {#s1}
============

The implementation of the bacterial CRISPR/Cas9 system in eukaryotes has triggered a quantum leap in targeted genome editing in literally any organism with a sequenced genome or targeting region ([@bib3]; [@bib8]; [@bib15]). Site-specific double-strand breaks (DSBs) are catalyzed by the Cas9 enzyme guided by a single RNA with a short complementary region to the target site. In response, the endogenous non-homologous end joining (NHEJ) DNA repair machinery seals the DSB. Since perfect repair will restore the CRISPR/Cas9 target site, mutations introduced by imprecise NHEJ are selected for.

To acquire precise genome editing the initial DSB should be fixed via the homology-directed repair (HDR) mechanism which is preferentially active during the late S/G2 phase of the cell cycle ([@bib6]). Donor DNA templates with flanking regions homologous to the target locus are used to introduce specific mutations or particular DNA sequences. Injected (linear) dsDNA rapidly multimerizes ([@bib23]), which likely also happens in CRISPR/Cas9 based approaches. Additionally, the high activity of NHEJ re-ligating CRISPR/Cas9 mediated DSBs can multimerize injected (linear) dsDNA donor templates. This poses a problem since consequently, the precise HDR-mediated recombination of single-copy donor templates is rather rare.

Several strategies have been followed to avoid NHEJ and/or favor HDR. NHEJ was interfered with by pharmacological inhibition of DNA ligase IV ([@bib16]). Conversely, HDR was meant to be favored by fusing the HDR-mediating yeast protein Rad52 to Cas9 ([@bib22]). Similarly, removal of Cas9 in the G1/S phase ([@bib4]) by linking it to the N-terminal region of the DNA replication inhibitor Geminin, should restrict the introduction of double-strand cuts to the G2 phase, when HDR is most prominently occurring ([@bib6]). Those approaches improved HDR-mediated integration of the homology flanks, while they did not tackle reported integration of multimers ([@bib1]) arising after injection of dsDNA templates such as plasmids or PCR products ([@bib23]).

Results {#s2}
=======

To enhance HDR without interfering with the endogenous DNA repair machinery, we aimed at establishing DNA donor templates that escape multimerization or NHEJ events. We thus blocked both 5´ends of PCR amplified long dsDNA donor cassettes using 'bulky' moieties like Biotin, Amino-dT (A-dT) and carbon spacers (e. g. Spacer C3, SpC3). This should shield the DNA donor from multimerization and integration via NHEJ, thus favoring precise and efficient single-copy integration via HDR ([Figure 1A](#fig1){ref-type="fig"}).

![Modification of 5' ends of long dsDNA fragments prevents in vivo multimerization.\
(**A**) Schematic representation of long dsDNA donor cassette PCR amplification with universal primers (black arrows) complementary to the cloning vector backbone outside of the assembled donor cassette (e. g. *gfp* with homology flanks). Bulky moieties like Biotin at the 5' ends of both modified primers (red octagon) prevent multimerization/NHEJ of dsDNA, providing optimal conditions for HDR-mediated single-copy integration following CRISPR/Cas9-introduced DSB at the target locus (grey scissors). Representation of locus (Lf/Lr) and internal *gfp* (Gf/Gr) primers for PCR genotyping of putative HDR-mediated *gfp* integration events. (**B**) Southern blot analysis reveals the monomeric state of injected dsDNA fragments in vivo for 5' modification with Biotin or Spacer C3. Long dsDNAs generated with control unmodified primers or Amino-dT attached primers multimerize as indicated by a high molecular weight ladder apparent already within two hours post-injection (hpi). Note: 5' moieties did not enhance the stability of injected DNA.](elife-39468-fig1){#fig1}

We first addressed the impact of the donor 5' modification on the formation of multimers in vivo. We injected modified and unmodified dsDNA donors into one-cell stage medaka (*Oryzias latipes*) embryos and analyzed the conformational state of the injected material during zygotic development. dsDNA donors were generated by PCR employing 5' modified and non-modified primers respectively, and by additionally providing traces of DIG-dUTP for labeling of the resulting PCR product. The conformation of the injected dsDNA donors was assayed in the extracted total DNA after 2, 4 and 6 hr post-injection, respectively. The DNA was size fractionated by gel electrophoresis and donor DNA conformation was detected after blotting the DNA to a nylon membrane by anti-DIG antibodies ([Figure 1B](#fig1){ref-type="fig"}). In unmodified DIG-labelled control donors, we uncovered multimerization already at 2 hr post-injection as evident by a ladder of labeled donor DNA representing different copy number multimers ([Figure 1B](#fig1){ref-type="fig"}). In contrast, Biotin and SpC3 modification of DIG-labelled donors prevented multimerization within six hours post-injection ([Figure 1B](#fig1){ref-type="fig"}). dsDNA donors established by A-dT modified primes, however, multimerized and produced similar results as unmodified DIG-labelled dsDNA donors ([Figure 1B](#fig1){ref-type="fig"}). Our results reveal that Biotin and SpC3 5' modifications efficiently prevent donor multimerization in vivo. While strongly blocking multimerization, the 5' modification of dsDNA did not apparently enhance the stability of the resulting dsDNA (compare modified and unmodified donors over time, [Figure 1B](#fig1){ref-type="fig"}).

To test whether 5' modification not only reduces the degree of multimerization but also impacts on single-copy HDR-mediated integration of long dsDNA donors, we designed *gfp* containing donor cassettes for an immediate visual readout. We generated *gfp* in-frame fusion donors for four different genes: the retinal homeobox transcription factors *rx2* and *rx1* ([@bib17]), the non-muscle cytoskeletal *beta-actin* (*actb*) ([@bib21]) and the *DNA methyltransferase 1* (*dnmt1*). Donor cassettes contained the respective 5' homology flank (HF) (462 bp for *rx2*, 430 bp for *rx1,* 429 bp for *actb*, 402 bp for *dnmt1*), followed by the in-frame *gfp* coding sequence, a flexible linker in case of *rx2, rx1* and *dnmt1*, and the corresponding 3' HF (414 bp for *rx2*, 508 bp for *rx1,* 368 bp for *actb*, 405 bp for *dnmt1*; schematic representation in [Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} for detailed donor design). To amplify the long dsDNA donors we employed a pair of universal primers (5' modified or unmodified as control) complementary to the backbone of the cloning vectors (pDestSC-ATG \[[@bib11]\] or pCS2+ \[[@bib19]\]) encompassing the entire assembled donor cassette ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

Modified or unmodified long dsDNA donors were subsequently co-injected together with *Cas9* mRNA and the respective locus-specific sgRNA into medaka one-cell stage zygotes ([@bib14]; [@bib18]). For all four loci (and all 5' modifications) tested we observed efficient targeting as apparent by the GFP expression within the expected expression domain ([Figure 2A](#fig2){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).

![Modification of 5' ends of long dsDNA fragments promotes HDR-mediated single-copy integration.\
(**A**) GFP expression in the respective expression domain after HDR-mediated integration of modified dsDNA *gfp* donor cassettes into *rx2*, *rx1*, *actb* and *dnmt1* ORFs in the injected generation. (**B**) Individual embryo PCR genotyping highlights efficient HDR-mediated single-copy integration of 5'Biotin modified long dsDNA donors, but not unmodified donor cassettes. Locus PCR reveals band size indicative of single-copy *gfp* integration (asterisk) besides alleles without *gfp* integration (open arrowhead). Amplification of *gfp* donor (white arrow) for control.](elife-39468-fig2){#fig2}

The survival rates of embryos injected with Biotin and SpC3 5' modified dsDNA donors did not differ significantly from embryos injected with the unmodified dsDNA control donors ([Supplementary file 1](#supp1){ref-type="supplementary-material"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). In contrast, the injection of the A-dT 5' modified dsDNA donors resulted in high embryonic lethality ([Supplementary file 1](#supp1){ref-type="supplementary-material"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).

We next analyzed the frequency of single-copy HDR events following a careful, limited cycle PCR approach on genomic DNA of GFP expressing embryos injected with unmodified, Biotin or SpC3 5' modified dsDNA donors. Our approach allowed distinguishing alleles without *gfp* integration (i.e. size of wild-type locus) from those generated by HDR and NHEJ respectively and addressed the size of the integration by a locus spanning PCR with a reduced number of PCR cycles (\<=30) to omit in vitro fusion-PCR artefacts (own data and \[[@bib24]\]). To determine the predictive power of GFP expression for perfect integration, we genotyped randomly selected, GFP-expressing embryos using locus primers (Lf/Lr) located distal to the utilized HFs ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) and addressed the fusion of the *gfp* donor sequence to the target genes ([Figure 2B](#fig2){ref-type="fig"}, [Figure 2---figure supplements 2](#fig2s2){ref-type="fig"} and [3](#fig2s3){ref-type="fig"}).

Employing unmodified donors, the rate of HDR was very low as evidenced by the predominant amplification of the alleles without *gfp* integration ([Figure 2B](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). In strong contrast, the 5' modified long dsDNA donors resulted in efficient HDR already detectable in the injected generation for all targeted loci. For the *gfp* tagging of *rx2*, 6 out of 10 randomly selected, GFP-expressing embryos showed precise HDR-mediated single-copy integration in F0 ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}) as sequence confirmed by the analysis of the locus ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). Thus, 9.5% of injected and surviving zygotes showed precise HDR-mediated single-copy integration (15.8% of the injected zygotes expressed GFP; 60% of those showed the precise single-copy integration; [Supplementary file 1](#supp1){ref-type="supplementary-material"}). For the *gfp* tagging of *actb* 46.5% of the injected zygotes expressed GFP, 35% of which (7 out of 20 randomly selected, GFP-expressing embryos) showed precise HDR-mediated single-copy integration in F0, accounting for 16.3% of the initially injected zygotes ([Supplementary file 1](#supp1){ref-type="supplementary-material"}).

In the case of *dnmt1*, the rate of precise HDR-mediated single-copy integration was even higher, since full gene functionality is required for the progression of development and embryonic survival. Here, strikingly, all GFP-expressing embryo showed the desired perfect integration.

We observed the highest efficiency of HDR targeting by 5' modified dsDNA for all loci tested for 5'Biotin modified donors ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Already in the injected generation we prominently detected and validated the HDR-mediated fusion of the long dsDNA donors with the respective locus ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). While still giving rise to a high percentage of HDR events, SpC3 5' modified dsDNA donors also resulted in elevated levels of additional bands indicative for the integration of higher order multimers and NHEJ events ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Even though increasingly popular, in our hands the use of RNPs (Cas9 protein and respective sgRNA) did not even get close to the efficiency achieved by co-injection of Cas9 mRNA and the corresponding sgRNA assessed by gene targeting as described above.

The precise integration detected in the injected generation was successfully transmitted to the next generation ([Figure 3](#fig3){ref-type="fig"}, [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). For *gfp-rx2*, 9% of fish originating from the initially injected embryos successfully transmitted the precisely modified locus to the next generation (15.8% of the injected embryos expressed GFP; 4 out of 7 GFP transmitting founder fish were also transmitting the precise single integration of the *gfp* donor cassette). For *gfp-rx1,* 3.9% of fish originating from the initially injected embryos were transmitting the precise single copy integrate to the next generation (13.5% of injected embryos expressed GFP; 2 out of 7 GFP transmitting founder fish were also transmitting the precise single integration of the *gfp-rx1* donor cassette). For *dnmt1*, the high rate of precise HDR-mediated single-copy integration observed in the injected generation was fully maintained in the transmission to the next generation due to the absolute requirement of a functional/functionally tagged version of the locus. As we found in the course of our study, the precise integration of the *gfp* donor cassette into the *actb* locus results in late embryonic lethality. Consequently, stable transgenic lines could not be established.

![Single-copy integration of long dsDNA donor establishes stably transmitted *gfp-rx2* fusion gene.\
(**A**) F2 homozygous embryos exhibit GFP-Rx2 fusion protein expression in the pattern of the endogenous gene in the retina. (**B**) Southern Blot analysis of F2 *gfp-rx2* embryos reveals a single band for a digestion scheme cutting outside the donor cassette (BglII/HindIII) or within the 5' donor cassette and in intron 2 (ScaI/HindIII) indicating precise single-copy donor integration. (**B'**) Schematic representation of the modified locus indicating the restriction sites and the domain complementary to the probe used in (**B**). (**C**) RT-PCR analysis on mRNA isolated from individual homozygous F3 embryos indicates the transcription of a single *gfp-rx2* fusion mRNA in comparison to the shorter wild-type *rx2* mRNA as schematically represented in (**C'**).](elife-39468-fig3){#fig3}

To estimate the timepoint of HDR events in the injected embryos, we investigated the actual rate of mosaicism in the germline as reflected by the germline transmission rate. For *gfp-rx2*, this rate ranged from 0.8% up to 12.9% indicating an HDR event earliest at the 4-cell stage (assuming that only a single event occurred per blastomere). In the case of *gfp-rx1,* HDR did not occur at the one-cell stage but rather later (2--8 cell stage as reflected by germline transmission rates of 23.9% and 5.8% respectively). Thus, for both cases, the transmission rates of the perfectly tagged locus reflect a level of mosaicism indicative for an HDR event between the 4- and 32-cell stage.

We addressed the nature of the insertion predicted to be single-copy by a combination of PCR and expression studies. We validated the genomic organization of the *gfp-rx2* ([Figure 3A](#fig3){ref-type="fig"}) and *gfp-rx1* knock-in in homozygous F2 animals by genomic sequencing ([Figure 2---figure supplement 3C](#fig2s3){ref-type="fig"}) and Southern Blot ([@bib20]) analysis ([Figure 3B and B'](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). In both cases, we detected a single band indicative for a single-copy HDR-mediated integration, when probing digested genomic DNA of F2 *gfp-rx2^+/+^* and *gfp-rx1^+/+^* knock-in fish respectively. We used enzyme combinations releasing the *gfp-rx2* region including the HFs (BglII/HindIII, [Figure 3B and B'](#fig3){ref-type="fig"}) or cutting in the 5' HF (ScaI/HindIII, [Figure 3B,B'](#fig3){ref-type="fig"}). For *gfp-rx1* we released the 5' flanking region including the donor cassette (HindIII/XmaI) or the respective 3' flanking region and donor cassette (NcoI/EcoRI) ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}).

This analyses crucially validated the PCR based predictions and sequencing results.

Furthermore, transcript analysis in *gfp-rx2* homozygous F3 embryos exclusively uncovered a single fusion *gfp-rx2* transcript ([Figure 3C and C'](#fig3){ref-type="fig"}). This molecular analysis confirmed that the 5'Biotin modification of the long dsDNA donor promoted precise single-copy HDR-mediated integration with high efficiency.

Taken together the simple 5'Biotin modification at both ends of long dsDNA donors by conventional PCR amplification presented here provides the means to favor HDR without interfering with the cellular DNA repair machinery.

Discussion {#s3}
==========

For efficient recombination the quality of the modified primers, that is the fraction of primers actually labeled with biotin and therefore the quality of the 5' protected long ds DNA PCR product, is essential. The integration of 5' modified PCR fragments larger than 2 kb does in principle not pose a problem. We already successfully integrated cassettes of up to 8.6 kb (data not shown) via HDR by in vivo linearization of the donor plasmid ([@bib21]). In the approach presented here, the quality of the end-protected PCR product is likely to drop with higher length in part due to the (UV--) nicking in the extraction and purification process. Also, the rapid validation by locus spanning PCR is size limited but eventually Southern blot analysis will resolve the question of a single copy, perfect integration. Irrespective of the donor cassette size, the PCR cycles used to probe for the successful single integration via HDR must not exceed a total of 30 to avoid misleading in vitro fusion-PCR artifacts (own data and \[[@bib24]\]).

As already mentioned earlier, HDR preferentially occurs during the late S/G2 phase of the cell cycle ([@bib5]; [@bib6]). Varying efficiencies of genome editing via HDR could be due to species-specific differences, in particular of the S/G2 phase of the cell cycle that likely crucially impacts on the rate of HDR. As reported extensively, there is no apparent G2 phase before mid-blastula-transition in amphibia (*Xenopus*) and fish (*Danio rerio*) with the marked exception of the first cleavage, where a G2 phase has been reported ([@bib9]). The germline transmission rates obtained for the tagging of Rx1 and Rx2 indicated HDR events after the two-cell stage, predominantly at the 4-cell and subsequent stages. The slower cycling of medaka compared to zebrafish results in an extension of the G2 phase in the first cell cycle by more than 150% (total cycle zebrafish: 45 min \[[@bib10]\], medaka: 65 min \[[@bib7]\]). Assuming a comparable rate of DNA synthesis between the two species, there is more than double the time for S- and M-phase to replicate a genome encompassing roughly a third of the size of zebrafish. This extended cell cycle length is in particular apparent also in the subsequent cycles in medaka (15 min zebrafish \[[@bib10]\], 40 min medaka \[[@bib7]\]). Interestingly, phosphorylation of RNA polymerase, a prerequisite for the expression of the first zygotic transcripts has been reported to start at the 64cell stage in medaka ([@bib13]) and asynchronous divisions, a hallmark of MBT, are observed already at the transition of the 16- to 32-cell stage ([@bib13]), suggesting species-specific differences in the onset of zygotic transcription and consequently the lengthening of the cell cycle.

Our approach facilitates the highly efficient detection of HDR events by GFP tagging even in non-essential genes. Other than in non-modified dsDNA donors, the locus-specific expression of GFP is an excellent predictor for precise, single-copy HDR-mediated integration already in the injected generation. This allows an easy selection and results in HDR rates in GFP positive embryos of up to 60% in the injected generation. This rate can even be higher in essential loci, such as *dnmt1*, where the full functionality of the (modified) gene under investigation is required for the survival of the affected cells, tissues, organs or organisms, thus providing the means for effective positive selection for single, fully functional integrates. It is interesting to note that approximately 400 bp flanking the insertion site in 5' and 3' direction are sufficient for HDR. The use of modified universal primers for the two donor template vectors employed allowed a flexible application of the procedure and ensured a high quality of the PCR generated 5' modified long dsDNA donors. Strikingly, the primer-introduced non-homology regions in the very periphery of the long dsDNA donors did not negatively impact on the HDR efficiency.

Taken together, the simplicity and high reproducibility of our proof-of-concept analysis highlight that the presented protection of both 5' ends of long dsDNA donors prevent multimerization and promote precise insertion/replacement of DNA elements, thus facilitating functional studies in basic research as well as therapeutic interventions.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\   Designation                  Source or reference   Identifiers   Additional information
  or resource                                                                                
  ------------------------- ---------------------------- --------------------- ------------- ----------------------------------------------
  Strain, strain\           Cab                          other                               medaka Southern wild-type population
  background\                                                                                
  (*Oryzias latipes*)                                                                        

  Strain, strain\           *rx2-gfp*                    this paper                          
  background\                                                                                
  (*Oryzias latipes*)                                                                        

  Strain, strain\           *rx1-gfp*                    this paper                          
  background\                                                                                
  (*Oryzias latipes*)                                                                        

  Strain, strain\           *actb-gfp*                   this paper                          
  background\                                                                                
  (*Oryzias latipes*)                                                                        

  Strain, strain\           *dnmt1-gfp*                  this paper                          
  background\                                                                                
  (*Oryzias latipes*)                                                                        

  Recombinant\              *rx2-gfp* donor cassette     this paper                          
  DNA reagent                                                                                

  Recombinant\              *rx1-gfp* donor cassette     this paper                          
  DNA reagent                                                                                

  Recombinant\              *actb-gfp* donor cassette    this paper                          
  DNA reagent                                                                                

  Recombinant\              *dnmt1-gfp* donor cassette   this paper                          
  DNA reagent                                                                                

  Sequence-\                rx2 5\'HF f                  this paper                          with BamHI restriction\
  based reagent                                                                              site: GCCGGATCCAAGCATGTCAAAACGTAGAAGCG

  Sequence-\                rx2 5\'HF r                  this paper                          with KpnI restriction site:\
  based reagent                                                                              GCCGGTACCCATTTGGCTGTGGACTTGCC

  Sequence-\                rx2 3\'HF f                  this paper                          with BamHI restriction site:\
  based reagent                                                                              GCCGGATCCCATTTGTCAATGGAC\
                                                                                             ACGCTTGGGATGGTGGACGAT

  Sequence-\                rx2 3\'HF r                  this paper                          with KnpI restriction site:\
  based reagent                                                                              GCCGGTACCTGGACTGGACTGGAAGTTATTT

  Sequence-\                rx2 sgRNA f                  this paper                          substituted nucleotides to facilitate T7\
  based reagent                                                                              in vitro transcription of the sgRNA\
                                                                                             oligonucleotides are shown in small letters\
                                                                                             TAgGCATTTGTCAATGGATACCC

  Sequence-\                rx2 sgRNA r                  this paper                          AAACGGGTATCCATTGACAAATG
  based reagent                                                                              

  Sequence-\                rx2 Lf/5'UTRf                this paper                          TGCATGTTCTGGTTGCAACG
  based reagent                                                                              

  Sequence-\                rx2 Lr                       this paper                          AGGGACCATACCTGACCCTC
  based reagent                                                                              

  Sequence-\                actb 5'HF f                  this paper                          with BamHI restriction site:\
  based reagent                                                                              GGGGATCCCAGCAACGACTTCGCACAAA

  Sequence-\                actb 5'HF r                  this paper                          with KnpI restriction site:\
  based reagent                                                                              GGGGTACCGGCAATGTCATCATCCATGGC

  Sequence-\                actb 3'HF f                  this paper                          with BamHI restriction site:\
  based reagent                                                                              GGGGATCCGACGACGATATAGCTG\
                                                                                             CACTGGTTGTTGACAACGGATCTG

  Sequence-\                actb 3'HF r                  this paper                          with KnpI restriction site:\
  based reagent                                                                              GGGGTACCCAGGGGCAATTCTCAGCTCA

  Sequence-\                actb sgRNA f                 this paper                          TAGGATGATGACATTGCCGCAC
  based reagent                                                                              

  Sequence-\                actb sgRNA r                 this paper                          AAACGTGCGGCAATGTCATCAT
  based reagent                                                                              

  Sequence-\                actb Lf                      this paper                          GTCCGAGTTGAGGGTGTCTG
  based reagent                                                                              

  Sequence-\                actb Lr                      this paper                          CATGTGCTCCACTGTGAGGT
  based reagent                                                                              

  Sequence-\                dnmt1 5'HF f                 this paper                          with SalI restriction site:\
  based reagent                                                                              AATTTGTCGACGCTTTGA\
                                                                                             CAGTTAACCTACACG

  Sequence-\                dnmt1 5'HF r                 this paper                          with AgeI restriction site:\
  based reagent                                                                              AATTTACCGGTCGTAACTGCA\
                                                                                             AACTAAAAAATAAAAC

  Sequence\                 dnmt1 3'HF f                 this paper                          with SpeI restriction site:\
  -based reagent                                                                             AATTTACTAGTATGCCATCCAGAA\
                                                                                             CGTCCTTATCTCTACCAGACGATG\
                                                                                             TCAGAAAAAGGTAC

  Sequence-\                dnmt1 3'HF r                 this paper                          with NotI restriction site:\
  based reagent                                                                              AATTTGCGGCCGCCTACACATA\
                                                                                             TTGTCTGTGATAC

  Sequence-\                mgfpf                        this paper                          with AgeI restriction site:\
  based reagent                                                                              AATTTACCGGTACTAGTACCATG\
                                                                                             AGTAAAGGAGAAGAACTTTTCAC

  Sequence-\                mgfpr                        this paper                          with SpeI restriction site:\
  based reagent                                                                              AATTTACTAGTCGCGGCTGCACTT\
                                                                                             CCACCGCCTCCCGATCCGCCACC\
                                                                                             GCCAGAGCCACCTCCGCCTGAAC\
                                                                                             CGCCTCCACCGCTCAGGCTAGCTT\
                                                                                             TGTATAGTTCATCCATGCCATG

  Sequence-\                dnmt1 sgRNA f                this paper                          substituted nucleotides to\
  based reagent                                                                              facilitate T7 in vitro\
                                                                                             transcription of the sgRNA\
                                                                                             oligonucleotides are shown\
                                                                                             in small letters\
                                                                                             TAgGACATCGTCTGGCAAAGAC

  Sequence-\                dnmt1 sgRNA r                this paper                          AAACGTCTTTGCCAGACGATGT
  based reagent                                                                              

  Sequence-\                dnmt1 Lf                     this paper                          CTCAATGTAAACACTTCGTGTCGCTTC
  based reagent                                                                              

  Sequence\                 dnmt1 Lr                     this paper                          TTGCATGCATATTCAAAGTTGTCAAAG
  -based reagent                                                                             

  Sequence-\                rx1 5'HF f                   this paper                          with BamHI restriction site:\
  based reagent                                                                              GCCGGATCCGCATCCGAAAGG\
                                                                                             TAAGGACTGCAAACC

  Sequence-\                rx1 5'HF r                   this paper                          with KpnI restriction site:\
  based reagent                                                                              GCCGGTACCCATGAGAGCG\
                                                                                             TCTGGGCTCTGACC

  Sequence-\                rx1 3'HF f                   this paper                          with BamHI restriction site:\
  based reagent                                                                              GGCGGATCCCATTTATCAC\
                                                                                             TCGATACCATGAGCA

  Sequence-\                rx1 3'HF r                   this paper                          with KpnI restriction site:\
  based reagent                                                                              GGCGGTACCTTCCAGTTTA\
                                                                                             AGAACATCCCCTCT

  Sequence-\                rx1 sgRNA1 f                 this paper                          substituted nucleotides to\
  based reagent                                                                              facilitate T7 in vitro\
                                                                                             transcription of the sgRNA\
                                                                                             oligonucleotides are shown\
                                                                                             in small letters\
                                                                                             TAggAAATGCATGAGAGCGTCT

  Sequence-\                rx1 sgRNA1 r                 this paper                          AAACAGACGCTCTCATGCATTT
  based reagent                                                                              

  Sequence-\                rx1 sgRNA2 f                 this paper                          substituted nucleotides to\
  based reagent                                                                              facilitate T7 in vitro\
                                                                                             transcription of the sgRNA\
                                                                                             oligonucleotides are shown\
                                                                                             in small letters\
                                                                                             TAggCTCTCATGCATTTATCAC

  Sequence-\                rx1 sgRNA2 r                 this paper                          AAACGTGATAAATGCATGAGAG
  based reagent                                                                              

  Sequence-\                rx1 Lf                       this paper                          CTTTGCTGTTTTGAGAATTGCACC
  based reagent                                                                              

  Sequence-\                rx1 Lr                       this paper                          GAGACCGAACGATGACAATAACAC
  based reagent                                                                              

  Sequence-\                pDest f (control)            this paper                          CGAGCGCAGCGAGTCAGTGAG
  based reagent                                                                              

  Sequence-\                pDest r (control)            this paper                          CATGTAATACGACTCACTATAG
  based reagent                                                                              

  Sequence-\                pDest f mod                  this paper                          Asterisks indicate phosphorothioate\
  based reagent                                                                              bonds, '5'moiety' was either\
                                                                                             5'Biotin, Amino-dT or Spacer C3.\
                                                                                             5'moiety-C\*G\*A\*G\*C\*GCAGCGAGTCAGTGAG

  Sequence-\                pDest r mod                  this paper                          Asterisks indicate phosphorothioate\
  based reagent                                                                              bonds, '5'moiety' was either 5'Biotin\
                                                                                             , Amino-dT or Spacer C3.\
                                                                                             5'moiety-C\*A\*T\*G\*T\*AATACGACTCACTATAG

  Sequence-\                pCS2 f                       this paper                          CCATTCAGGCTGCGCAACTG
  based reagent                                                                              

  Sequence-\                pCS2 r                       this paper                          CACACAGGAAACAGCTATGAC
  based reagent                                                                              

  Sequence\                 pCS2 f mod                   this paper                          Asterisks indicate phosphorothioate\
  -based reagent                                                                             bonds, '5'moiety' was either\
                                                                                             5'Biotin, Amino-dT or Spacer C3.\
                                                                                             5'moiety-C\*C\*A\*T\*T\*CAGGCTG\
                                                                                             CGCAACTG

  Sequence-\                pCS2 r mod                   this paper                          Asterisks indicate phosphorothioate\
  based reagent                                                                              bonds, '5'moiety' was either\
                                                                                             5'Biotin, Amino-dT or Spacer C3.\
                                                                                             5'moiety-C\*A\*C\*A\*C\*AGGAAACAGCTATGAC

  Sequence-\                Gf                           this paper                          ATGGCAAGCTGACCCTGAAGTTCAT\
  based reagent                                                                              CTGCACCACCGGCAAGC

  Sequence-\                Gr                           this paper                          CTCAGGTAGTGGTTGTCG
  based reagent                                                                              

  Sequence-\                gfpf                         this paper                          GCTCGACCAGGATGGGCA
  based reagent                                                                              

  Sequence-\                gfpr                         this paper                          CTGAGCAAAGACCCCAACGAGA\
  based reagent                                                                              AGCGCGATCACATG

  Sequence-\                gfp probe f                  this paper                          GTGAGCAAGGGCGAGGAGCT
  based reagent                                                                              

  Sequence-\                gfp probe r                  this paper                          CTTGTACAGCTCGTCCATG
  based reagent                                                                              
  -----------------------------------------------------------------------------------------------------------------------------------------

Fish maintenance {#s4-1}
----------------

All fish are maintained in closed stocks at Heidelberg University. Medaka (*Oryzias latipes*) husbandry (permit number 35--9185.64/BH Wittbrodt) and experiments (permit number 35--9185.81/G-145/15 Wittbrodt) were performed according to local animal welfare standards (Tierschutzgesetz §11, Abs. 1, Nr. 1) and in accordance with European Union animal welfare guidelines ([@bib2]). The fish facility is under the supervision of the local representative of the animal welfare agency. Embryos of medaka of the wild-type Cab strain were used at stages prior to hatching. Medaka was raised and maintained as described previously ([@bib12]).

Donor plasmids {#s4-2}
--------------

*Rx2* and *actb* template plasmids for *gfp* donor cassette amplification are described in [@bib21] and were generated by GoldenGATE assembly into the pGGDestSC-ATG destination vector (addgene \#49322) according to [@bib11]. See [Supplementary file 2](#supp2){ref-type="supplementary-material"} for primers used to amplify respective homology flanks. The *dnmt1 gfp* plasmid was cloned with homology flanks (5' HF 402 bp, primers dnmt1 5'HF f/dnmt1 5'HF r; 3' HF 405 bp, dnmt1 3'HF f/dnmt1 3'HF r) that were PCR amplified with Q5 polymerase (New England Biolabs, 30 cycles) from wild-type medaka genomic DNA. *mgfp-flexible linker* was amplified with primers mgfpf/mgfpr. The respective restriction enzyme was used to digest the amplicons (5'HF: SalI HF (New England Biolabs), AgeI HF (New England Biolabs); *mgfp-flexible linker*: AgeI HF (New England Biolabs), SpeI HF (New England Biolabs); 3'HF: SpeI HF (New England Biolabs), NotI HF (New England Biolabs)) followed by gel purification (Analytik Jena) and ligation into pCS2+ ([@bib19]) (digested with SalI HF (New England Biolabs), NotI HF (New England Biolabs)). The *rx1 gfp* plasmid was cloned with homology flanks (5'HF 430 bp, primers rx1 5'HF f/rx1 5'HF r; 3' HF 508 bp, rx1 3'HF f/rx1 3'HF r) that were PCR amplified with Q5 polymerase (New England Biolabs, 30 cycles) from wild-type medaka genomic DNA. All primers were obtained from Eurofins Genomics.

Donor amplification {#s4-3}
-------------------

We designed universal primers that match the pGGDestSC-ATG ([@bib11]) (addgene \#49322) or pCS2+ ([@bib19]) backbone encompassing the assembled inserts (i.e. the *gfp* donor cassette). Unmodified control primers (pDest f, pDest r, pCS2 f, pCS2 r) were ordered from Eurofins Genomics. Modified primers obtained from Sigma-Aldrich (pDest f mod, pDest r mod, pCS2 f mod, pCS2 r mod) consist of the same sequences with phosphorothioate bonds in the first five nucleotides and 5'moiety extension: 5'Biotin, 5'Amino-dT or 5'Spacer C3.

The dsDNA donor cassettes were amplified by PCR using 1x Q5 reaction buffer, 200 µM dNTPs, 200 µM primer forward and reverse and 0.6 U/µl Q5 polymerase (New England Biolabs). Conditions used: initial denaturation at 98°C 30 s, followed by 35 cycles of: denaturation at 98°C 10 s, annealing at 62°C 20 s and extension at 72°C 30 s per kb and a final extension step of 2 min at 72°C. The PCR reaction was treated with 20 units of DpnI (New England Biolabs) to remove any plasmid template following gel purified using the QIAquick Gel Extraction Kit (Qiagen, 28706) and elution with 20 µl nuclease-free water.

The *LacZ* cassette of the pGGDestSC-ATG ([@bib11]) (addgene \#49322) which served as DIG labelled dsDNA fragment to test in vivo multimerization was amplified via Q5-PCR as above using a mixture of 200 µM dATP, dCTP, dGTP, 170 µM dTTP and 30 µM DIG-dUTP and purified as detailed.

sgRNA target site selection {#s4-4}
---------------------------

*Dnmt1* sgRNAs were designed with CCTop as described in [@bib21]. sgRNAs for *rx2* and *actb* were the same as in [@bib21]. The following target sites close to the translational start codons were used (PAM in brackets): *rx2* (GCATTTGTCAATGGATACCC\[TGG\]), *actb* (GGATGATGACATTGCCGCAC\[TGG\]), *dnmt1* (TGACATCGTCTGGCAAAGAC\[AGG\]) and *rx1* (AAATGCATGAGAGCGTCT\[GGG\] and CTCTCATGCATTTATCAC\[TGG\]). Cloning of sgRNA templates and in vitro transcription was performed as detailed in [@bib21].

In vitro transcription of mRNA {#s4-5}
------------------------------

The pCS2 +*Cas9* plasmid was linearized using NotI and the mRNA was transcribed in vitro using the mMessage_mMachine SP6 kit (ThermoFisher Scientific, AM1340).

Microinjection and screening {#s4-6}
----------------------------

Medaka zygotes were injected with 10 ng of DIG-labelled donors and were allowed to develop until 2, 4 and 6 hr post injection. For the CRISPR/Cas9 experiments, medaka zygotes were injected with 5 ng/µl of either unmodified and modified long dsDNA donors together with 150 ng/µl of *Cas9* mRNA and 15--30 ng/µl of the gene-specific sgRNAs. Injected embryos were maintained at 28°C in embryo rearing medium (ERM, 17 mM NaCl, 40 mM KCl, 0.27 mM CaCl~2~, 0.66 mM MgSO~4~, 17 mM Hepes). One day post-injection (dpi) embryos were screened for survival, GFP expression was scored at two dpi.

Southern blot {#s4-7}
-------------

In order to check for multimerization of unmodified and modified donors, we used a modified Southern Blot approach. In brief, embryos were injected with DIG-labelled donors which were PCR-amplified from pGGDestSC-ATG (addgene \#49322) using primers pDest f/pDest r (*LacZ* cassette) harboring either no 5' moiety or one of the following: 5'Biotin, Amino-dT or Spacer C3. 2, 4 and 6 hr post injection, 30 embryos were lysed in TEN buffer plus proteinase K (10 mM Tris pH 8, 1 mM EDTA, 100 mM NaCl, 1 mg/ml proteinase K) at 60°C overnight. DNA was ethanol precipitated after removal of lipids and proteins by phenol-chloroform extraction. Total DNA was resuspended in TE buffer (10 mM Tris HCl pH 8.0, 1 mM EDTA pH 8.0). 200 ng of each sample was run on a 0.8% agarose gel. As a control, 100 pg of uninjected donor PCR product were loaded. The agarose gel was transferred to a nylon membrane overnight using 10x SSC (1.5 M NaCl, 0.15 M C~6~H~5~Na~3~O~7~) as transfer solution. The cross-linked membrane was directly blocked in 1% w/v blocking reagent (Roche) in 1x DIG1 solution (0.1 M maleic acid, 0.15 M NaCl, pH 7.5) and the labeled DNA was detected using CDP star (Roche) following the manufacturer's instructions.

In order to check for copy number insertions in the *gfp-rx2* and *gfp-rx1* transgenic lines, genomic DNA was isolated as described above from F2 embryos expressing GFP. 10 µg digested genomic DNA were loaded per lane on a 0.8% agarose gel and size fractionated by electrophoresis. The gel was depurinated in 0.25 N HCl for 30 min at room temperature, rinsed with H~2~O, denatured in 0.5 N NaOH, 1.5 M NaCl solution for 30 min at room temperature and neutralized in 0.5 M Tris HCl, 1.5 M NaCl, pH 7.2 before it was transferred overnight at room temperature onto a Hybond membrane (Amersham). The membrane was washed with 50 mM NaPi for 5 min at room temperature, then crosslinked and pre-hybridized in Church hybridization buffer (0.5 M NaPi, 7% SDS, 1 mM EDTA pH 8.0) at 65°C for at least 30 min. The probe was synthesized from the donor plasmid with primers gfp probe f and gfp probe r using the PCR DIG Probe Synthesis Kit (Roche, 11636090910) and the following PCR protocol: initial denaturation at 95°C for 2 min, 35 cycles of 95°C 30 s, 60°C 30 s, 72°C 40 s and final extension at 72°C 7 min. The probe was boiled in hybridization buffer for 10 min at 95°C and the membrane was hybridized overnight at 65°C. The membrane was washed with pre-heated (65°C) Church washing buffer (40 mM NaPi, 1% SDS) at 65°C for 10 min, then at room temperature for 10 min and with 1x DIG1% and 0.3% Tween for 5 min at room temperature. The membrane was blocked in 1% w/v blocking reagent (Roche) in 1x DIG1 solution at room temperature for at least 30 min. The membrane was incubated with 1:10,000 anti-digoxigenin-AP Fab fragments (Roche) for 30 min at room temperature in 1% w/v blocking reagent (Roche) in 1x DIG1 solution. Two washing steps with 1x DIG1% and 0.3% Tween were performed for 20 min at room temperature, followed by a 5 min washing step in 1x DIG3 (0.1 M Tris pH 9.5, 0.1 M NaCl) at room temperature. Detection was performed using 6 µl/ml CDP star (Roche).

Genotyping {#s4-8}
----------

Single injected GFP positive embryos were lysed in DNA extraction buffer (0.4 M Tris/HCl pH 8.0, 0.15 M NaCl, 0.1% SDS, 5 mM EDTA pH 8.0, 1 mg/ml proteinase K) at 60°C overnight. Proteinase K was inactivated at 95°C for 10 min and the solution was diluted 1:2 with H~2~O. Genotyping was performed in 1x Q5 reaction buffer, 200 µM dNTPs, 200 µM primer forward and reverse and 0.012 U/µl Q5 polymerase and 2 µl of diluted DNA sample and the respective locus primers. The conditions were: 98°C 30 s, 30 cycles of 98°C 10 s, annealing for 20 s and 72°C 30 s per kb (extension time used would allow for detecting potential NHEJ events on both ends of the donor) (rx2 Lf/rx2 Lr: 68°C annealing, 90 s extension time; rx1 Lf/rx1 Lr: 66°C annealing, 90 s extension time; actb Lf/actb Lr: 66°C annealing, 84 s extension time; dnmt1 Lf/dnmt1 Lr: 65°C annealing, 90 s extension time) and a final extension of 2 min at 72°C. PCR products were analyzed on a 1% agarose gel.

Diagnostic GFP PCR here: 63°C annealing, 500 bp, 15 s extension

RT-PCR {#s4-9}
------

Total RNA was isolated from 60 homozygous embryos (stage 32) by lysis in TRIzol (Ambion) and chloroform extraction according to the manufacturer's protocol. RNA was precipitated using isopropanol and resuspended in H~2~O. cDNA was reverse transcribed with Revert Aid Kit (Thermo Fisher Scientific) after DNAse digestion and inactivation following the manufacturer's instructions. PCR was performed using 5'UTRf, 3'UTRr and Q5 polymerase (New England Biolabs): 98°C 30 s, 35 cycles of 98°C 10 s, annealing 65°C for 20 s and 72°C 210 s and a final extension of 2 min at 72°C. PCR products were analyzed on a 1.5% agarose gel.

Sequencing {#s4-10}
----------

Plasmids and PCR fragments were sequenced with the indicated primers by a commercial service (Eurofins Genomics).
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###### Analysis of injected embryos.

Embryos injected with unmodified or modified (5'Biotin, Amino-dT, Spacer C3) long dsDNA *gfp* donor cassettes matching the *rx2*, *actb*, *dnmt1* or *rx1* locus, were scored for GFP expression and survival. Injections without *Cas9* mRNA for control.

10.7554/eLife.39468.013

###### Oligonucleotides used in this work.

Restriction enzyme sites used for cloning of PCR amplicons are indicated in italics. Substituted nucleotides to facilitate T7 in vitro transcription of the sgRNA oligonucleotides are shown in small letters ([@bib21]). Locus primers forward (Lf) and reverse (Lr) of respective gene loci, *gfp* primers forward (Gf) and reverse (Gr), *gfp* sequencing primers gfpf and gfpr and primers to amplify the *mgfp-flexible linker*, as well as the *gfp* probe for Southern Blot analysis, are given. Asterisks indicate phosphorothioate bonds, '5'moiety' was either 5'Biotin, Amino-dT or Spacer C3 in the pDest f mod, pDest r mod, pCS2 f mod and pCS2 r mod primers.

10.7554/eLife.39468.014

Data availability {#s7}
-----------------

All data generated or analyzed during this study are included in the manuscript and supporting files. Source data files have been provided for Figure 2-figure supplement 1.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Efficient single-copy HDR by 5\' modified long dsDNA donors\" for consideration by *eLife*. Your article has been reviewed by 2 peer reviewers, including Alejandro Sánchez Alvarado as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Jessica Tyler as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Manfred Schartl (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This well-written manuscript provides a very attractive protocol for efficient gene knock-in with CRISPR/Cas9 through homology-directed repair. The authors used a streamlined strategy (modification of 5\' ends of long dsDNA donors with either biotin or carbon spacers) to successfully address a common problem in the field of genome editing: multimerization of donor molecules in vivo and therefore interference with non-homologous end joining (NHEJ). The authors show in particular that 5\' modification with biotin leads to a high frequency of single copy HDR events in injected embryos and confirmed that the modified locus was stably transmitted to offspring with remarkably high efficiency for single copy integrations.

If this method is as efficient as reported, precise genome editing by homologous recombination using CRISPR/Cas9 stands to become more the norm than the exception. Therefore, given the likely broad appeal and interest, this method is likely to generate, the following questions must be addressed by the authors:

Essential revisions:

1\) In both the Abstract and the main text, authors assert that the new method reported produces \"60% efficiency\". However, 60% (6 out of 10 GFP positive fish are germline transformed) is the highest efficiency obtained for one of the three genes tested (6 out of 10 GFP positive fish are germline transformed). Unless I missed it, the efficiency for the other two genes was not reported. This information should be provided. If the efficiency is as high as reported, such numbers should be easy to generate and ideally, more genes could have been readily tested.

2\) Also, clarification on how the efficiency of transformation was calculated is needed. As it stands, the calculation of efficiency reported in this manuscript is somewhat misleading. A less ambiguous method to report efficiency may be to indicate the minimum number of embryos that need to be injected to get germline transformation. For example, if the injection of 100 embryos gives 60% efficiency, then the efficiency is high. However, if 1000 embryos need to be injected get 60% efficiency, then the efficiency is low.

10.7554/eLife.39468.017

Author response

> 1\) In both the Abstract and the main text, authors assert that the new method reported produces \"60% efficiency\". However, 60% (6 out of 10 GFP positive fish are germline transformed) is the highest efficiency obtained for one of the three genes tested (6 out of 10 GFP positive fish are germline transformed). Unless I missed it, the efficiency for the other two genes was not reported. This information should be provided. If the efficiency is as high as reported, such numbers should be easy to generate and ideally, more genes could have been readily tested.

The referees are touching a crucial point of the manuscript that we apparently had not been able to sufficiently highlight in the submitted version. We have taken care to move all the relevant numbers from the supplemental table to the main text and have in addition extended the manuscript and the supplemental table by additional data concerning the results on tagging of Rx1. Related to the number of injected embryos surviving the procedure, efficiencies range from 4-16% .

We have furthermore taken care to fully explain the tagging of *Dnmt1*, an essential gene. Here only unedited embryos or those with a functional fusion protein survive. This results in a much higher tagging efficiency and thus reflects an interesting selection strategy.

> 2\) Also, clarification on how the efficiency of transformation was calculated is needed. As it stands, the calculation of efficiency reported in this manuscript is somewhat misleading. A less ambiguous method to report efficiency may be to indicate the minimum number of embryos that need to be injected to get germline transformation. For example, if the injection of 100 embryos gives 60% efficiency, then the efficiency is high. However, if 1000 embryos need to be injected get 60% efficiency, then the efficiency is low.

Similar to request 1 we now fully explain the rationale behind the efficiency calculation. We relate all efficiencies to the number of surviving, injected embryos (100%). We first screen for injected embryos expressing GFP. Among these we validate the quality integration (in the injected generation) and now relate that number back to the survivors (instead of only relating it back to the number of GFP positive embryos). While those numbers had been presented in the supplemental table of the submitted version, we now consistently calculate all efficiencies relative to the number of injected surviving embryos.

This gives the reader immediate access to the number of embryos to be injected for likely obtaining a perfect HDR mediated gene fusion. In all cases presented, an injection of less than 100 embryos (20 minutes of work) resulted in several founders efficiently transmitting a perfect fusion to the next generation.

[^1]: Escuela de Microbiología, Facultad de Salud, Universidad Industrial, Santander, Colombia.

[^2]: These authors contributed equally to this work.
